CLIMB BIO INC (CLYM) Stock Income Statement
NASDAQ:CLYM - Nasdaq - US28658R1068 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 27.00M | 21.47M | 45.14M | 35.67M | 20.93M | |||
| Research and Development | 11.61M | 11.58M | 26.21M | 23.32M | 18.50M | |||
| Selling, General, and Administrative Expenses | 15.39M | 9.89M | 18.92M | 12.35M | 2.43M | |||
| Operating Income | -27.00M | -21.47M | -45.14M | -35.67M | -20.93M | |||
| Interest Income/Expense | 8.12M | 5.16M | -1.48M | -170.00K | 260.00K | |||
| Other Income/Expense | N/A | N/A | 1.38M | -11.64M | 0.00 | |||
| Non Recurring Items | -55.02M | -18.81M | N/A | N/A | N/A | |||
| Income Before Taxes | -73.90M | -35.12M | -45.24M | -47.48M | -20.67M | |||
| Net Income | -73.90M | -35.12M | -45.24M | -52.03M | -22.95M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.53 | -1.30 | -1.72 | -4.24 | -0.91 | |||
| Non GAAP EPS | N/A | N/A | -1.72 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD